# Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

> **NCT03497572** · — · COMPLETED · sponsor: **Imaxio** · enrollment: 145 (actual)

## Conditions studied

- Leptospirosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03497572
- **Lead sponsor:** Imaxio
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-25
- **Primary completion:** 2018-04-12
- **Final completion:** 2018-04-12
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2018-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497572, "Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03497572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*